Emcure Pharma To Launch Molnupiravir For Emergency Use In A Week�s Time In India
[email protected]11 Jan, 2022News
Emcure Pharmaceuticals Limited (EPL) has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India (DGCI) for the launch of Molnupiravir, an investigational oral antiviral drug, for the treatment of mild COVID-19. EPL plans to launch molnupiravir under the brand name Lizuvira in the Indian market.
Related Bookmarks
- Emcure Pharma To Launch DCGI Approved Oral Covid-19 Drug, Molnupiravir In A Week�s Time In India
- Shark Tank India Infuses INR 75 Lakh Into Bummer
- How to Embed Yelp Reviews on Website
- 12 of the Best Makeup Gift Sets to Give to All Beauty Lovers in Your Life
- Does Bathroom Refurbishment in Bexley Seem Preferable?
- Hydrostor stock: Why are investors looking for it & can it be bought?
- REVIEWING YOUR FAVORITE BRUCE BANNER STRAIN
- 13 Best Lip Balms to Soothe and Hydrate Dry, Chapped Lips
- Enhance the Longevity of Your Home Through Pressure Washing in Teddington
- The Ultimate Guide To Chromatography
Recent Profiles
Jun88casino Top
Steven Hassanali
Titan Construction
Multivoucherde
Thybo Bauer
Gps Computer Academy
Elfbarfinland
5abet
Brow Lamination Course
Schou Hoffman